Gait-speed and oxygen flow during six-minute walk test predicts mortality in patients with advanced lung disease

Submitted: October 15, 2019
Accepted: January 21, 2020
Published: February 12, 2020
Abstract Views: 1564
PDF: 658
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The six-minute walk test (6MWT) is a useful tool to predict outcomes in patients with advanced lung diseases. Greater distance walked has been shown to have more favorable prognostic value compared to other recorded variables.  We reviewed the medical records of 164 patients with advanced lung disease who underwent lung transplant evaluation. Results of the 6MWT (distance walked, oxygen required, and mean gait speed) were recorded and analyzed with respect to mortality. 6MWT mean oxygen (O2) flow via nasal cannula was 3.5 ± 3.7 L/min. The distance walked in meters (m) and % predicted were inversely associated with mortality, OR: 0.995 (0.992-0.998) and 0.970 (0.950-0.990), respectively. Patients who walked < 200 meters (OR: 2.1 (1.1-4.0)) or < 45% of predicted, OR: 2.7 (1.2-5.7) had higher mortality. O2 flow during the test had a direct association with mortality (OR: 1.1 (1.0-1.2). In multivariate analysis, O2 flow > 3.5 L/min remained predictive of mortality, OR: 1.1 (1.0-1.2). Mean gait speed was higher in patient who lived compared with patients who died (mean 0.83 ± 0.35 m/mim vs mean 0.69 ± 0.33 m/min, respectively, p= 0.03). Gait speed was a predictor of survival, OR 3.4 (1.1, 10.6). O2 flow during the 6MWT was an independent predictor of mortality in patients with advanced lung disease. The patients that required more than 3.5 L/m of O2 had a higher mortality. Faster gait speed during the 6MWT was also associated with better survival.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Irina Timofte, University of Maryland School of Medicine

Irina Timofte MD MS University of Maryland School of Medicine, Baltimore, Maryland, United States, Department of Medicine, Division of Pulmonary and Critical Care; the work was performed at University of Florida, Gainesville, Florida, USA

Adriano Tonelli, University of Maryland School of Medicine

Diaz-Abad, Montserrat MD University of Maryland School of Medicine, Baltimore, Maryland, United States, Department of Medicine, Division of Pulmonary and Critical Care

Montserrat Diaz-Abad, University of Maryland School of Medicine

Diaz-Abad, Montserrat MD University of Maryland School of Medicine, Baltimore, Maryland, United States,
Department of Medicine, Division of Pulmonary and Critical Care

Avelino Verceles, University of Maryland School of Medicine

Avelino Verceles MD University of Maryland School of Medicine, Baltimore, Maryland, United States,
Department of Medicine, Division of Pulmonary and Critical Care

Olufemi Akindipe, Cleveland Clinic

Olufemi Akindipe MD Cleveland Clinic, Cleveland, Ohio, United States, Department of Pulmonary and Critical
Care, Respiratory Institute

Maher Baz, University of Kentucky

Maher Baz MD University of Kentucky, Lexington, United States, Department of Lung Transplantation

How to Cite

Timofte, Irina, Adriano Tonelli, Montserrat Diaz-Abad, Avelino Verceles, Nicholas Ladikos, Aldo Iacono, Martin L. Terrin, Marniker Wijesinha, Olufemi Akindipe, and Maher Baz. 2020. “Gait-Speed and Oxygen Flow During Six-Minute Walk Test Predicts Mortality in Patients With Advanced Lung Disease”. Monaldi Archives for Chest Disease 90 (1). https://doi.org/10.4081/monaldi.2020.1186.